Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Procter & Gamble
PG
$335B
| $28.3M | 0.04% |
314,800
-556,300
| -64% | -$49.3M |
|
602
Orthofix Medical
OFIX
$424M
| $28.3M | 0.04% |
740,579
-5,000
| -0.7% | -$185K |
|
|
BRSS
603
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $28.2M | 0.04% |
818,800
+61,900
| +8% | +$2.11M |
|
604
Las Vegas Sands
LVS
$29.6B
| $28.2M | 0.04% |
493,500
-909,400
| -65% | -$49.5M |
|
605
Onto Innovation
ONTO
$20.6B
| $28.1M | 0.04% |
923,600
+174,100
| +23% | +$4.71M |
|
|
CIT
606
DELISTED
CIT Group Inc.
CIT
| $28M | 0.04% |
651,600
-255,700
| -28% | -$10.8M |
|
|
CAB
607
DELISTED
Cabela's Inc
CAB
| $27.9M | 0.04% |
524,500
+385,500
| +277% | +$19.8M |
|
|
ETFC
608
DELISTED
E*Trade Financial Corporation
ETFC
| $27.8M | 0.04% |
798,140
-16,900
| -2% | -$606K |
|
609
Hain Celestial
HAIN
$52.9M
| $27.8M | 0.04% |
746,622
+507,900
| +213% | +$19.1M |
|
610
ATN International
ATNI
$478M
| $27.7M | 0.04% |
394,000
+4,600
| +1% | +$350K |
|
611
8x8 Inc
EGHT
$290M
| $27.7M | 0.04% |
1,818,430
+119,930
| +7% | +$1.82M |
|
|
RP
612
DELISTED
RealPage, Inc.
RP
| $27.7M | 0.04% |
792,394
+170,794
| +27% | +$5.58M |
|
|
GCP
613
DELISTED
GCP Applied Technologies Inc.
GCP
| $27.6M | 0.04% |
844,500
+385,231
| +84% | +$11.1M |
|
614
Provident Financial Services
PFS
$3.24B
| $27.5M | 0.04% |
1,064,100
+68,100
| +7% | +$1.81M |
|
615
Mettler-Toledo International
MTD
$28.8B
| $27.5M | 0.04% |
+57,400
| New | +$26.2M |
|
616
DuPont de Nemours
DD
$19.5B
| $27.4M | 0.04% |
170,549
-701,941
| -80% | -$109M |
|
|
VIVO
617
DELISTED
Meridian Bioscience Inc
VIVO
| $27.4M | 0.04% |
1,988,276
+115,076
| +6% | +$1.61M |
|
|
FBR
618
DELISTED
Fibria Celulose Sa
FBR
| $27.4M | 0.04% |
2,997,000
-803,800
| -21% | -$7.3M |
|
|
PDLI
619
DELISTED
PDL BioPharma, Inc.
PDLI
| $27.3M | 0.04% |
12,036,754
-838,946
| -7% | -$1.86M |
|
620
CNA Financial
CNA
$13.7B
| $27.3M | 0.04% |
617,700
-140,000
| -18% | -$5.96M |
|
621
Rambus
RMBS
$11B
| $27.3M | 0.04% |
2,076,200
+110,000
| +6% | +$1.45M |
|
622
CAE Inc. Common Shares
CAE
$8.9B
| $27.2M | 0.04% |
1,777,500
+574,900
| +48% | +$8.42M |
|
623
Norfolk Southern
NSC
$75.3B
| $27.1M | 0.04% |
+242,100
| New | +$28.3M |
|
624
Ternium
TX
$10.8B
| $27.1M | 0.04% |
1,037,000
-168,900
| -14% | -$4.2M |
|
625
Tanger
SKT
$4.42B
| $27M | 0.04% |
824,500
-31,100
| -4% | -$1.05M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.